Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows – The New York Times

by

  1. Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows The New York Times
  2. Novo Nordisk: Wegovy heart benefits due to more than weight loss Reuters
  3. Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else? CNN
  4. Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds The Associated Press
  5. Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine Yahoo Finance
  6. View Full Coverage on Google News

Read original article here

Leave a Comment